These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2154307)

  • 1. Prevention of Rh(D) alloimmunization: a cost-benefit analysis.
    Baskett TF; Parsons ML
    CMAJ; 1990 Feb; 142(4):337-9. PubMed ID: 2154307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Economic analysis of the prevention of anti-D immunization].
    Ravinet J; Carbonne B
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S104-1S111. PubMed ID: 16495835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antepartum Rh immune globulin.
    Wible-Kant J; Beer AE
    Clin Perinatol; 1983 Jun; 10(2):343-55. PubMed ID: 6311476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACOG releases report on prevention of D isoimmunization.
    Am Fam Physician; 1991 Jan; 43(1):307-8, 310. PubMed ID: 1846056
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of antenatal anti-D prophylaxis.
    Vick S; Cairns J; Urbaniak S; Whitfield C; Raafat A
    Health Econ; 1996; 5(4):319-28. PubMed ID: 8880168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology.
    Int J Gynaecol Obstet; 1999 Jul; 66(1):63-70. PubMed ID: 10458556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal suppression of Rh alloimmunization.
    Bowman JM
    Clin Obstet Gynecol; 1991 Jun; 34(2):296-303. PubMed ID: 1651184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Rh sensitization in the context of trauma: two case reports.
    Werch JB
    J Clin Apher; 2010; 25(2):70-3. PubMed ID: 20027640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antepartum prophylaxis: the final step in the Rh isoimmunization problem?].
    Brandes J; Fisher M
    Harefuah; 1989 Nov; 117(10):340-1. PubMed ID: 2559005
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of the management of rh-negative pregnant women.
    Duplantie J; Gonzales OM; Bois A; Nshimyumukiza L; Gekas J; Bujold E; Morin V; Vallée M; Giguère Y; Gagné C; Rousseau F; Reinharz D
    J Obstet Gynaecol Can; 2013 Aug; 35(8):730-740. PubMed ID: 24007709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?
    Bowman JM
    Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.
    Hawk AF; Chang EY; Shields SM; Simpson KN
    Obstet Gynecol; 2013 Sep; 122(3):579-85. PubMed ID: 23921866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
    Med Lett Drugs Ther; 1996 Jan; 38(966):6-8. PubMed ID: 8544794
    [No Abstract]   [Full Text] [Related]  

  • 18. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
    Crane JP; Rohland B; Larson D
    Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG.
    Ayache S; Herman JH
    Transfusion; 2008 Sep; 48(9):1990-9. PubMed ID: 18564395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advantages of preventing Rh isoimmunization].
    Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
    Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.